Inhibition of PC cell-derived growth factor (PCDGF, epithelin/granulin precursor) expression by antisense PCDGF cDNA

R Lu1, G Serrero

  • 1Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, 20 North Pine Street, Baltimore, MD 21201-1180, USA.

Insights

PC-cell derived growth factor (PCDGF) promotes breast cancer growth and tumorigenicity. Inhibiting PCDGF significantly reduced tumor formation in preclinical models, highlighting its potential as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • PC-cell derived growth factor (PCDGF) is linked to tumorigenicity in teratoma cells.
  • PCDGF expression is estrogen-dependent in estrogen receptor-positive (ER(+)) human mammary epithelial cells.
  • PCDGF is structurally related to the epithelin/granulin precursor.

Purpose of the Study:

  • To investigate PCDGF expression in various human mammary epithelial cell lines, from nontumorigenic to ER(+) and ER(-) breast carcinoma cells.
  • To determine the role of PCDGF as an autocrine growth factor in ER(-) breast carcinoma cells.
  • To evaluate the impact of PCDGF inhibition on the proliferation and tumorigenicity of breast cancer cells.

Main Methods:

  • Northern and Western blot analyses to assess PCDGF mRNA and protein levels.
  • Treatment with anti-PCDGF neutralizing antibody to study proliferation inhibition.
  • Antisense PCDGF cDNA transfection to inhibit PCDGF expression in vitro and in vivo.
  • Assessment of cell proliferation, colony formation, tumor incidence, and tumor weight.

Main Results:

  • PCDGF expression levels correlated positively with tumorigenicity across cell lines.
  • Neutralizing PCDGF antibody inhibited proliferation of ER(-) breast carcinoma cells.
  • Inhibition of PCDGF expression via antisense cDNA reduced in vitro proliferation and colony formation.
  • Antisense PCDGF cells showed significantly reduced tumor incidence (90%) and weight in vivo.

Conclusions:

  • PCDGF overexpression is crucial for the proliferation and tumorigenicity of ER(-) breast carcinomas.
  • Secreted PCDGF acts as an autocrine growth factor in breast cancer.
  • PCDGF represents a potential therapeutic target for human breast cancer.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...